Joshua Hammond, MD
Family Medicine · Lamar, CONPI 1831621200
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (44.2%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Skeletal Dynamics Inc at 44.2% of the total. Reporting peaked in 2021 at $2,986 and has fallen 80.4% since, to $586 in 2025. Among family medicine clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 107 payments — averaging $59.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Skeletal Dynamics Inc$3K
- Gilead$2K
- Indivior Inc.$895
- Orexo US, Inc.$275
- Alkermes, Inc.$121
- AbbVie$44
- plus $52 from 2 others
What the payments were for
- Consulting fees$1,79028%
- Travel & lodging$2,79744%
- Food & beverage$1,74528%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Skeletal Dynamics Inc | 2 | $2,797 |
| Gilead | 21 | $2,146 |
| Indivior Inc. | 57 | $895 |
| Orexo US, Inc. | 15 | $275 |
| Alkermes, Inc. | 7 | $121 |
| AbbVie | 2 | $44 |
| USWM, LLC | 2 | $33 |
| Braeburn Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,331 in reported general payments places this provider in the 95th percentile of 2,079 family medicine providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 40 | $3,794 |
| Buprenorphine Hcl | 21 | $534 |
| Hydrochlorothiazide | 14 | $41 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Lamar
- Ethan LazarusDenver$688K
- Michael de NardisLarkspur$335K
- Matthew YoungColorado Springs$270K
- Mark DeutchmanDenver$258K
- Kari UusinarkausWoodland Park$254K
- Michael MeekerUsaf Academy$174K
- Carolynn Francavilla BrownLakewood$174K
- Lawrence AndrewsColorado Springs$102K
- Gregory MaederWestminster$95K
- Paul SimmonsGrand Junction$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.